<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <id type="integer">569</id>
  <cancdbp-id>CDBP00568</cancdbp-id>
  <name>Ubiquitin-conjugating enzyme E2 L3</name>
  <uniprot-id>P68036</uniprot-id>
  <uniprot-name>UB2L3_HUMAN</uniprot-name>
  <enzyme type="boolean">true</enzyme>
  <transporter type="boolean">false</transporter>
  <protein-type>Enzyme</protein-type>
  <organism>Homo_sapiens</organism>
  <gene-name>UBE2L3</gene-name>
  <num-residues type="integer">154</num-residues>
  <molecular-weight type="decimal">24003.385</molecular-weight>
  <theoretical-pi type="decimal">8.742</theoretical-pi>
  <general-function>Involved in acid-amino acid ligase activity</general-function>
  <specific-function>Ubiquitin-conjugating enzyme E2 that specifically acts with HECT-type and RBR family E3 ubiquitin-protein ligases. Does not function with most RING-containing E3 ubiquitin-protein ligases because it lacks intrinsic E3-independent reactivity with lysine: in contrast, it has activity with the RBR family E3 enzymes, such as PARK2 and ARIH1, that function like function like RING-HECT hybrids. Accepts ubiquitin from the E1 complex and catalyzes its covalent attachment to other proteins. In vitro catalyzes 'Lys-11'-linked polyubiquitination. Involved in the selective degradation of short-lived and abnormal proteins. Down-regulated during the S-phase it is involved in progression through the cell cycle. Regulates nuclear hormone receptors transcriptional activity. May play a role in myelopoiesis.
</specific-function>
  <signal-regions type="array"/>
  <transmembrane-regions type="array"/>
  <pdb-ids>1C4Z;1FBV;3SQV;3SY2</pdb-ids>
  <genbank-gene-id>S81003</genbank-gene-id>
  <genbank-protein-id nil="true"/>
  <genecard-id>UBE2L3</genecard-id>
  <chromosome-location>22</chromosome-location>
  <locus>22q11.21</locus>
  <geneatlas-id>UBE2L3</geneatlas-id>
  <hgnc-id>HGNC:12488</hgnc-id>
  <export type="boolean">true</export>
  <comment nil="true"/>
  <kegg-id>hsa:7332</kegg-id>
  <meta-cyc-id></meta-cyc-id>
  <ncbi-sequence-ids>NP_001243284.1:NM_001256355.1;NP_001243285.1:NM_001256356.1;NP_003338.1:NM_003347.3</ncbi-sequence-ids>
  <tissue-specificity>Ubiquitous, with highest expression in testis.
</tissue-specificity>
  <cofactor></cofactor>
  <subunit>Interacts with PARK2; involved in ubiquitination and degradation of misfolded proteins. Interacts with UBE3A; used by the papilloma virus HPV-16 E6 protein to ubiquitinate p53/TP53. Interacts with CCNB1IP1, CBL, ZAP70, RNF19A, RNF19B and RNF144B. Interacts with ARIH1. Interacts with ARIH2 (via RING-type 1). Interacts with NCOA1; they functionally interact to regulate progesterone receptor transcriptional activity. May interact with NR3C1
</subunit>
  <cellular-location nil="true"/>
  <ec-number nil="true"/>
  <created-at type="dateTime">2020-06-12T23:06:50Z</created-at>
  <updated-at type="dateTime">2020-07-28T02:25:41Z</updated-at>
  <description nil="true"/>
  <receptor type="integer">0</receptor>
  <metal-binding type="integer">0</metal-binding>
  <trans-factor type="integer">1</trans-factor>
</protein>

